Skip to main content
Clinical Trials/DRKS00022509
DRKS00022509
Recruiting
Not Applicable

Prospective pilotstudy for the development and evaluation of softwaretools for non-invasive assessment of fibrosis and steatosis of the liver with machine learning methods

Goethe-Universität Frankfurt am Main0 sites80 target enrollmentNovember 26, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
K76.0
Sponsor
Goethe-Universität Frankfurt am Main
Enrollment
80
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 26, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of a non\-alcoholic fatty liver disease

Exclusion Criteria

  • \- Alcohol consumption \= 20 g/d in female and \= 30 g/d in male patients
  • \- Decompensated cirrhosis of the liver
  • \- Viral hepatitis
  • \- Non\-viral primary or secondary liver diseases other than NAFLD/NASH
  • \- Malignancies (except for basalioma) within the last 5 years, in particular primary or secondary liver tumors
  • \- Orthotopic liver transplantation
  • \- Any comedication known to cause hepatic steatosis (i.e. steroids, Methotrexate, Amiodarone, Tamoxifen, Valproate, Flutamide, etc.)
  • \- Clinically relevant heart insufficiency, cardiac arrhythmias, relevant cardiac valve diseases
  • \- Pregnancy and lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials